These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38816991)

  • 1. Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD).
    Venkatesan D; Muthukumar S; Iyer M; Babu HWS; Gopalakrishnan AV; Yadav MK; Vellingiri B
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23741. PubMed ID: 38816991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.
    Huat TJ; Camats-Perna J; Newcombe EA; Valmas N; Kitazawa M; Medeiros R
    J Mol Biol; 2019 Apr; 431(9):1843-1868. PubMed ID: 30664867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formaldehyde, Epigenetics, and Alzheimer's Disease.
    Wang F; Chen D; Wu P; Klein C; Jin C
    Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the focal role of endostatin and environmental factors in Alzheimer's disease.
    Behl T; Dahim MA; Aleya L
    Environ Sci Pollut Res Int; 2024 Jul; 31(32):44511-44517. PubMed ID: 38951391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
    Ejaz HW; Wang W; Lang M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
    Wang P; Wang ZY
    Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity.
    Vellingiri B; Suriyanarayanan A; Selvaraj P; Abraham KS; Pasha MY; Winster H; Gopalakrishnan AV; G S; Reddy JK; Ayyadurai N; Kumar N; Giridharan B; P S; Rao KRSS; Nachimuthu SK; Narayanasamy A; Mahalaxmi I; Venkatesan D
    Chemosphere; 2022 Aug; 301():134625. PubMed ID: 35439490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?
    Chin-Chan M; Cobos-Puc L; Alvarado-Cruz I; Bayar M; Ermolaeva M
    J Biol Inorg Chem; 2019 Dec; 24(8):1285-1303. PubMed ID: 31773268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases.
    Rahman MA; Rahman MS; Uddin MJ; Mamum-Or-Rashid ANM; Pang MG; Rhim H
    Environ Sci Pollut Res Int; 2020 Dec; 27(36):44659-44672. PubMed ID: 32201908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.
    Cavaleri F
    Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
    He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
    Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
    Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
    Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
    Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
    Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Zaman S; Begum Y; Ashraf GM; Bin-Jumah MN; Bungau SG; Mousa SA; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):1-20. PubMed ID: 32889653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.